Published in Medicine and Law Weekly, October 20th, 2006
Importantly, SCV-07 taken orally resulted in only 10% plasma level variability between all volunteers in this study, demonstrating highly predictable plasma concentrations after oral dosing of this drug.
This phase 1 pilot study was designed to evaluate the oral availability of SCV-07 in healthy volunteers. A total of 24 volunteers were randomized into one of three groups receiving SCV-07 in an oral tablet,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.